Loss of normal Alzheimer's disease-associated Presenilin 2 function alters antiseizure medicine potency and tolerability in the 6-Hz focal seizure model
IntroductionPatients with early-onset Alzheimer's disease (EOAD) experience seizures and subclinical epileptiform activity, which may accelerate cognitive and functional decline. Antiseizure medicines (ASMs) may be a tractable disease-modifying strategy; numerous ASMs are marketed with well-establis...
Na minha lista:
| Principais autores: | , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Frontiers Media S.A.
2023-08-01
|
| Serier: | Frontiers in Neurology |
| Fag: | |
| Online adgang: | https://www.frontiersin.org/articles/10.3389/fneur.2023.1223472/full |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|
